X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55) 55
index medicus (48) 48
female (43) 43
hematology (43) 43
male (41) 41
middle aged (40) 40
life sciences (34) 34
adult (31) 31
aged (24) 24
oncology (20) 20
cancer (17) 17
treatment outcome (15) 15
adolescent (14) 14
aged, 80 and over (14) 14
survival rate (12) 12
[sdv.can]life sciences [q-bio]/cancer (11) 11
leukemia, myeloid, acute - drug therapy (11) 11
remission induction (11) 11
retrospective studies (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
chemotherapy (9) 9
risk factors (9) 9
abridged index medicus (8) 8
acute myeloid-leukemia (8) 8
disease-free survival (8) 8
immunology (8) 8
leukemia, myeloid, acute - mortality (8) 8
mutation (8) 8
prognosis (8) 8
survival (8) 8
leukemia (7) 7
prospective studies (7) 7
transplantation (7) 7
[ sdv.can ] life sciences [q-bio]/cancer (6) 6
[sdv]life sciences [q-bio] (6) 6
adults (6) 6
aml (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
diagnosis (6) 6
hemic and lymphatic diseases (6) 6
induction chemotherapy (6) 6
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (6) 6
stem-cell transplantation (6) 6
survival analysis (6) 6
time factors (6) 6
transplantation, homologous (6) 6
young adult (6) 6
acute lymphoblastic leukemia (5) 5
acute myelogenous leukemia (5) 5
antineoplastic agents - therapeutic use (5) 5
antineoplastic combined chemotherapy protocols (5) 5
bone marrow - pathology (5) 5
france (5) 5
hematopoietic stem cell transplantation (5) 5
hematopoietic stem cell transplantation - adverse effects (5) 5
multicenter (5) 5
older patients (5) 5
polycythemia-vera (5) 5
precursor cell lymphoblastic leukemia-lymphoma - mortality (5) 5
research (5) 5
acute disease (4) 4
acute myeloid leukemia (4) 4
analysis (4) 4
antineoplastic agents - administration & dosage (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
bone marrow (4) 4
bone marrow transplantation (4) 4
children (4) 4
classification (4) 4
clinical trials (4) 4
cytarabine - administration & dosage (4) 4
daunorubicin (4) 4
dna mutational analysis (4) 4
essential thrombocythemia (4) 4
genetic aspects (4) 4
hematology, oncology and palliative medicine (4) 4
human health and pathology (4) 4
medicine & public health (4) 4
minimal residual disease (4) 4
mortality (4) 4
myelodysplastic syndromes - genetics (4) 4
myeloproliferative neoplasms (4) 4
philadelphia chromosome (4) 4
prognostic-factors (4) 4
risk (4) 4
transplantation, autologous (4) 4
1st complete remission (3) 3
[ sdv ] life sciences [q-bio] (3) 3
[ sdv.imm ] life sciences [q-bio]/immunology (3) 3
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (3) 3
acute lymphocytic leukemia (3) 3
age factors (3) 3
anemia (3) 3
articles (3) 3
asparaginase (3) 3
biopsy (3) 3
bleeding disorder (3) 3
cancer-patients (3) 3
cell transplantation (3) 3
cells (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Jaillette, Emmanuelle and Girault, Christophe and Brunin, Guillaume and Zerimech, Farid and Chiche, Arnaud and Broucqsault-Dedrie, Céline and Fayolle, Cyril and Minacori, Franck and Alves, Isabelle and Barrailler, Stephanie and Robriquet, Laurent and Delaporte, Emmanuel and Thellier, Damien and Delcourte, Claire and Duhamel, Alain and Nseir, Saad and Valette, Xavier and Desmeulles, Isabelle and Savary, Benoit and Masson, Romain and Seguin, Amélie and Daubin, Cédric and Sauneuf, Bertrand and Verrier, Pierre and Pottier, Véronique and Orabona, Marie and Samba, Désiré and Viquesnel, Gérald and Lermuzeaux, Mathilde and Hazera, Pascal and Hanouz, Jean-Luc and Parienti, Jean-Jacques and Du Cheyron, Damien and Demoule, Alexandre and Clavel, Marc and Rolland-Debord, Camille and Perbet, Sébastien and Terzi, Nicolas and Kouatchet, Achille and Wallet, Florent and Roze, Hadrien and Vargas, Frédéric and Guérin, Claude and Dellamonica, Jean and Jaber, Samir and Similowski, Thomas and Quenot, Jean-Pierre and Binquet, Christine and Vinsonneau, Christophe and Barbar, Saber-Davide and Vinault, Sandrine and Deckert, Valérie and Lemaire, Stephanie and Hssain, Ali Ait and Bruyère, Rémi and Souweine, Bertrand and Lagrost, Laurent and Adrie, Christophe and Jung, Boris and Daurat, Aurelien and De Jong, Audrey and Chanques, Gérald and Mahul, Martin and Monnin, Marion and Molinari, Nicolas and Lheureux, Olivier and Trepo, Eric and Hites, Maya and Cotton, Frederic and Wolff, Fleur and Surin, Rudy and Créteur, Jacques and Vincent, Jean-Louis and Gustot, Thierry and Jacobs, Frederique and Taccone, Fabio Silvio and Neuville, Mathilde and Timsit, Jean-François and El-Helali, Najoua and Le Monnier, Alban and Magalhaes, Eric and Radjou, Aguila and Smonig, Roland and Soubirou, Jean-François and Voiriot, Guillaume and Sonneville, Romain and Bouadma, Lila and Mourvillier, Bruno and Gélisse, Elodie and Brasseur, Alexandre and Roisin, Sandrine and De Backer, Daniel and Van Ruychevelt, Valerie and Carlier, Eric and Piagnerelli, Michael and Vanhaeverbeek, Michel and Danguy, Christine and Biston, Patrick and Au, Siu-Ming and Begot, Emmanuelle and ... and Qualité et Sécurité des Soins - CBPR-CFAR and Brain Liver Pitié-Salpêtrière Study Group (BLIPS), Paris, France and Working Group on Mechanical Ventilation and Outcomerea Study Group and COCOONs Study Group and Groupe ALIVE and For the GrrrOH: Groupe de recherche en réanimation respiratoire en Onco-Hématologie (Group for Research in Respiratory Intensive Care Onco-Hematology and EPURE Study Group and For the OUTCOMEREA Study Group and For the BIBLIOFLASH Study Group and Groupe de Recherche en Réanimation Respiratoire et Onco-Hematologique (GRRROH) and RETROMARS Study Group and BoReal study group and ABDOMIX Group and Groupe de travail sur la ventilation and Groupe de Recherche en Reanimation Respiratoire du patient d’Onc-hématologie and Groupe RMM and Université Paris 6 —Pierre et Marie Curie and Institut National pour la Santé et la Recherche Médicale, UMRS1158, Paris and Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie and ABLE French Investigators and ENCEPHALITICA Study Group and Septiflux trial Group and CRICS Network and OutcomeRéa and Committee of young intensivists of the French Society for Intensive Care Medicine (FICS) and NutriSIP and CNER DESC réanimation grand ouest and Phase Angle Project Investigators
Annals of Intensive Care, ISSN 2110-5820, 6/2016, Volume 6, Issue S1, pp. 1 - 236
PHYSICIANS ABSTRACTSO1 Impact of tracheal cuff shape on microaspiration of gastric contents in intubated critically ill patients: a multicenter randomized... 
Intensive / Critical Care Medicine | Emergency Medicine | Anesthesiology | Medicine & Public Health
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 11, pp. 1044 - 1053
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 811 - 818
Purpose: The GRASPALL/GRAALL‐SA2‐2008 Phase II trial evaluated the safety and efficacy of L‐asparaginase encapsulated within erythrocytes (GRASPA®) in patients... 
ADULT PATIENTS | THERAPY | OLDER PATIENTS | COLI ASPARAGINASE | DOXORUBICIN | RANDOMIZED-TRIAL | REGIMEN | RED-BLOOD-CELLS | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | CHILDRENS ONCOLOGY GROUP | Humans | Middle Aged | Gram-Positive Bacterial Infections - mortality | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Erythrocytes - chemistry | Antifungal Agents - therapeutic use | Drug Carriers | Anti-Bacterial Agents - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Drug Compounding | Erythrocytes - cytology | Female | Gram-Positive Bacterial Infections - complications | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Asparaginase - therapeutic use | Philadelphia Chromosome | Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | Gram-Negative Bacterial Infections - pathology | Antineoplastic Combined Chemotherapy Protocols | Gram-Negative Bacterial Infections - complications | Gram-Negative Bacterial Infections - drug therapy | Remission Induction | Gram-Positive Bacterial Infections - pathology | Asparagine - metabolism | Mycoses - pathology | Mycoses - drug therapy | Survival Analysis | Aged | Mycoses - complications | Mycoses - mortality | Gram-Positive Bacterial Infections - drug therapy | Gram-Negative Bacterial Infections - mortality | Oncology, Experimental | Clinical trials | Genetic research | Asparagine | Aged patients | Genetic aspects | Acute lymphocytic leukemia | Research | Cancer | Index Medicus | Life Sciences
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2015, Volume 90, Issue 11, pp. 986 - 991
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2013, Volume 162, Issue 4, pp. 489 - 497
Summary In tumour lysis syndrome (TLS), metabolic alterations caused by the destruction of malignant cells manifest as laboratory abnormalities with (clinical... 
haemodialysis | acute kidney failure | haematologic malignancy | hyperphosphataemia | intensive care units | Intensive care units | Hyperphosphataemia | Acute kidney failure | Haemodialysis | Haematologic malignancy | BURKITT LYMPHOMA/LEUKEMIA | PREVENTION | ACUTE-RENAL-FAILURE | RECOMBINANT URATE OXIDASE | PREDICTIVE MODEL | ACUTE MYELOID-LEUKEMIA | CHEMOTHERAPY | CANCER-PATIENTS | HYPERURICEMIA | HEMATOLOGY | CRITICALLY-ILL PATIENTS | Fluid Therapy | Urate Oxidase - therapeutic use | Prevalence | Prospective Studies | Hematologic Neoplasms - mortality | Humans | Middle Aged | Tumor Lysis Syndrome - blood | Male | Renal Replacement Therapy - utilization | Tumor Lysis Syndrome - etiology | Tumor Lysis Syndrome - epidemiology | Adult | Female | Acute Kidney Injury - chemically induced | Hematologic Neoplasms - complications | Drug Therapy, Combination | Urate Oxidase - administration & dosage | Acute Kidney Injury - drug therapy | Comorbidity | Acute Kidney Injury - blood | Risk Factors | Proportional Hazards Models | Tumor Burden | Remission Induction | Disease-Free Survival | Allopurinol - therapeutic use | Bicarbonates - administration & dosage | Allopurinol - administration & dosage | Hyperphosphatemia - etiology | Biomarkers | Hematologic Neoplasms - drug therapy | Hyperphosphatemia - drug therapy | Acute Kidney Injury - therapy | Aged | Tumor Lysis Syndrome - drug therapy | Acute Kidney Injury - epidemiology
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2019, Volume 25, Issue 8, pp. 2483 - 2493
Purpose: Biological explanation for discrepancies in patient-related response to chemotherapy depending on the underlying oncogenic events is a promising... 
CYTOGENETIC ABNORMALITIES | SYNTHETASE EXPRESSION | CELLS | ONCOLOGY | STANDARD-RISK | ACUTE LYMPHOBLASTIC-LEUKEMIA | GENE-EXPRESSION | RESISTANCE | ADULTS | HOX11L2 EXPRESSION | CHILDREN | Life Sciences | Immunology | Adaptive immunology | Cancer
Journal Article
European Journal of Haematology, ISSN 0902-4441, 05/2017, Volume 98, Issue 5, pp. 443 - 449
Journal Article
Blood, ISSN 0006-4971, 05/2016, Volume 127, Issue 19, pp. 2356 - 2358
Journal Article
Journal Article